FDA Commissioner on Need for New COVID Vaccine Trial Data

Need for Updated COVID Vaccine Data

• 💡 Dr. Marty Makary, FDA Commissioner, states that updated data on COVID vaccines, in the randomized controlled trial (RCT) fashion typically required by the FDA, has not been available for four to five years.
• 🎯 He emphasizes that the current situation is different from the initial rollout of Operation Warp Speed due to broad population immunity and a changed virus.
• 🔑 Makary questions the necessity of numerous future COVID shots for individuals, stating that the medical community has not demonstrated the humility to admit uncertainty.

Concerns with Existing Data and Trump's Claims

• 🔍 Makary notes that data presented to him is often "salami sliced" into subgroups and comes from observational studies, not proper clinical trials.
• 🗣️ He addresses President Trump's claims of seeing extraordinary, unpublished Pfizer data, explaining that the FDA is not receiving that specific information.
• 🤝 An agreement has been reached with major vaccine manufacturers to conduct RCTs with results expected by May, aiming to provide clarity on vaccine efficacy and safety.

Vaccine Injury and Risk-Benefit Analysis

• ⚠️ Makary acknowledges reports of vaccine injury and complications, including deaths, but states that these represent a very small minority of vaccine recipients.
• 📈 He highlights the known risk of myocarditis in young, healthy males (1 in 2600), underscoring the nuanced nature of medical science.
• ⚖️ The core question remains whether the benefits of the vaccine outweigh the risks, a point that should not be ignored or blindly accepted.

Moving Forward with Evidence-Based Science

• 🚫 The FDA will not continue the practice of annually rubber-stamping COVID boosters without updated clinical trial evidence.
• ✅ The focus is on bringing back "gold standard science and common sense" to vaccine evaluations.